Articles tagged with Colorectal Cancer
A large population-based study found that long-term smokers who never used NSAIDs had the highest risk of colon cancer. Smokers using NSAIDs still faced a 30% higher risk than nonsmokers. The study suggests NSAIDs may not counteract smoking's adverse effects on colorectal-cancer risk.
Researchers have developed a new test to detect rare genetic mutations in families at risk of passing on hereditary cancers like FAP. The innovative test allows for precise detection of mutations, enabling couples to make informed decisions about their pregnancies.
The study demonstrated a statistically significant benefit of FOLFIRI in patients with metastatic colorectal cancer, improving progression-free survival and overall survival. Adding bevacizumab to FOLFIRI also showed improved outcomes, with a higher percentage of patients alive after one year.
Long-term cancer survivors experience ongoing concerns about cancer recurrence and treatment side effects, affecting their mental health. Research found that these worries are linked to depression and anxiety, with varying levels of concern across different types of cancer.
A study analyzed data from over 35,975 individuals who underwent colonoscopy without detecting colorectal neoplasia. The results showed a significant decrease in colorectal cancer incidence at 6 months (31%) and persisted for more than 10 years. A negative colonoscopy was associated with a lower risk of developing CRC.
Researchers used small interfering RNAs to block the spread of human colorectal cancer cells in laboratory mice, achieving a major reduction in liver cancer growth. The treatment also showed potential for increased cancer cell killing when combined with standard chemotherapeutic agents.
A series of articles ranks preventive services by their cost-effectiveness and population health benefits, highlighting influenza vaccines and colorectal cancer screening as top priorities. The studies show that these services can save thousands of years of life and prevent deaths, with significant potential for improving overall healt...
Researchers recommend pre-screening to avoid worst liver damage caused by chemotherapy drugs. The study found that irinotecan was associated with steatohepatitis and oxaliplatin with sinusoidal dilation, which can lead to liver disease and failure.
Panitumumab significantly improves progression-free survival and disease control in patients with mCRC, with a median duration of response of 17 weeks. The treatment was well-tolerated, with few major adverse reactions.
Researchers found that MMP-9 is highly expressed by colon cancer cells and is key to initiating metastasis. By blocking the enzyme, colorectal cancer cells cannot metastasize to other tissue, suggesting a new target for preventing metastasis in colon cancer.
Current smokers and drinkers are diagnosed with colorectal cancer an average of 7.8 years younger than non-users, according to a new study. Flexible sigmoidoscopy may not detect proximal cancers as effectively as colonoscopy.
Researchers found a decreased risk of colorectal cancer for those taking high SSRI doses before diagnosis. The study's results provide interesting insights but highlight the need for further investigation and trial data.
Researchers found that individuals who smoke and drink developed colon cancer an average of 7.8 years earlier than non-users, with women showing a significant gap in cancer diagnosis age compared to men. The study suggests tailoring individualized screening programs based on tobacco and alcohol consumption.
Scientists discover that vitamin D can regulate an oncogenic protein called beta-catenin, which is involved in colon cancer development. A drug mimic of vitamin D could potentially prevent some cancers at early stages, but may not be effective for late-stage cancers.
A research group identified 679 genes differently expressed in responders to chemotherapy compared to non-responders. RT-PCR analysis validated the findings, confirming the differential expression of 22 genes. The study suggests integrating molecular networks could improve diagnosis and treatment of colorectal cancer.
Regular screening significantly reduces cancer deaths in families with hereditary Lynch syndrome, with a 70% decrease in mortality rates. Additionally, research finds that people with IBD-related CRC have similar prognoses as the general population, while a self-propelling colonoscope shows promise in efficient and safe detection.
The APC tumor suppressor has a novel function in regulating Wnt signaling in the nucleus. In this new study, researchers demonstrate that APC opposes beta-catenin activity directly at Wnt target genes. The findings suggest that full-length APC protein is necessary to repress c-Myc gene expression and prevent colon cancer progression.
Researchers found that hepatic arterial infusion (HAI) therapy extended survival and improved quality of life in patients with colorectal cancer that has spread to the liver. HAI therapy resulted in a median survival of 24 months, better response rates, and longer time to disease progression compared to systemic chemotherapy.
Researchers found a 12% reduction in hip fractures among women taking supplements, but only those who adhered to the full dosage saw benefits. Women over 50 should prioritize dietary sources of calcium and Vitamin D for bone health.
The study found a small but significant increase in hip bone density among women taking calcium combined with vitamin D. However, the supplements had no detectable effect on colorectal cancer incidence or spine fractures.
A study led by Dr. Richard Goldberg found that the chemotherapy regimen FOLFOX4 is effective in treating colorectal cancer regardless of age, including older patients over 70. The analysis of nearly 4,000 patients showed consistent benefits and side effects across all age groups.
A recent study found that low-income minority patients are underrepresented in colon cancer screenings, with only 7% receiving correct screenings. The study highlights the need for organizational interventions to support physicians in underserved areas and promote recommended screening practices.
Researchers tracked over 8 years and found no reduction in colorectal cancer cases with low-fat diet intervention. The study suggests that mid-to-late life dietary changes may not significantly impact colorectal cancer risk.
A study of nearly 49,000 postmenopausal women found a modest reduction in breast cancer incidence among those with high fat intake, but this benefit was not seen in those who reduced their fat intake. Women should focus on reducing saturated and trans fats, increasing vegetable consumption, and maintaining regular exercise for overall ...
Research on women with HIV found that those infected with both HIV and high-risk HPV were at greatest risk of developing cervical cancer precursors. A study on postmenopausal women found sex hormone levels to be not associated with breast cancer risk, while another study suggested that BRCA2 mutation carriers had a fourfold increased i...
Researchers propose a simple test that identifies more accurately individuals who might have colorectal cancer when used alongside traditional guaiac tests. This new approach could decrease the number of false positives in screening programs and reduce the need for colonoscopy, potentially leading to improved accuracy and reduced costs.
A large study of over 4000 participants found no association between statin use and reduced risk of colorectal cancer. The researchers noted that if statins strongly reduced the risk, any cholesterol-lowering drug would likely show some reduction in risk due to shared users.
Researchers found L1 in large quantities exclusively in aggressive colon cancer cells, enabling them to invade and metastasize more effectively. The discovery may have important implications for diagnosing colon cancer and designing new therapies.
A high-fiber diet from whole plant foods, but not isolated to cereal consumption, has been related to lower risks of chronic conditions such as heart disease and diabetes. However, a pooled analysis of 13 prospective cohort studies found no association between dietary fiber intake and reduced risk of colorectal cancer.
A new study found that increased physical activity is associated with a decreased risk of breast cancer in both black women and white women, regardless of disease stage or family history. Additionally, research on plant compound deguelin suggests it may interfere with tobacco-induced lung cancer development, while high plasma levels of...
A combination treatment of Xeloda and oxaliplatin (XELOX) has been shown to reduce hospital visits by over 60% in patients with early colon cancer. This results in more time for patients to spend with family and return to work, improving their quality of life.
Colorectal cancer affects millions across Europe, with a rapidly aging population highlighting the need for improved screening and prevention strategies. Researchers highlight irinotecan combined with 5-fluorouracil as an effective treatment regimen.
A recent study found that smoking significantly increases the risk of colorectal cancer in women, with the effect being more pronounced than in men. The researchers also discovered that colon cancer screening is beneficial for patients aged 75 and older, despite potential complications from endoscopy.
New studies show that young African Americans are at a much higher risk of developing pre-cancerous polyps compared to other racial groups. The American College of Gastroenterology recommends that African Americans begin colonoscopy screening at age 45, as opposed to the current recommended age of 50.
A randomized controlled trial found that a top-down approach to promoting colorectal cancer screening in physician organizations had no effect on increasing screening rates. However, the study identified key characteristics, such as integrated medical groups and regular physical exams, which could be targeted for future interventions.
A study found that CT colonography can detect cancer lesions and polyps with nearly the same sensitivity as colonoscopy, avoiding fatal perforations but potentially leading to more cancer-related deaths. The method's higher cost is offset by its non-invasive nature and appeal to patients.
A study found that managed care programs failed to increase colorectal cancer screening rates, with only 26% of eligible patients receiving screening. The intervention program aimed to improve screening practices but had little impact after two years.
Researchers discovered that TGFBR1*6A, a gene variant, significantly increases the risk of developing metastases in colorectal and head & neck cancers. In the presence of TGF-beta, cancer cells with this gene variant exhibit a selective growth advantage.
A recent study found that 50-94% of colorectal tumors have DNA gene changes, which could indicate a molecular defect. The study also found normal colon mucosa up to 10cm away from the tumor had similar gene changes.
Long-term and regular aspirin use is associated with a significant reduction in colorectal cancer risk, with benefits observed at doses of 14 tablets per week or more. The study found that the risk of colorectal cancer decreased by up to 53% among women who took high-dose aspirin for over 10 years.
A study found that long-term aspirin use lowers the risk of invasive colorectal cancer, especially in those taking high doses for more than 10 years. However, serious gastrointestinal bleeding risk increases with higher doses.
The largest study to date provides valuable insights into flexible sigmoidoscopy screening among 154,942 participants aged 55-74. Findings show that women are more likely to decline FSG than men, while non-acceptance increases with age in women. The rate of cancer detected was 2.9 per 1,000 individuals screened.
A new study found long-duration regular use of aspirin or NSAIDs may lower prostate cancer risk by 18%. Gene variants associated with melanoma risk were also identified in a Mediterranean population study, while another study found no link between gene mutations and response to bevacizumab
Research estimates a lifetime cancer risk of 0.14% and 0.022% from virtual colonoscopy, with the colon, stomach, and bladder being at greatest risk. While low radiation risks are promising, practical issues such as bowel preparation and patient compliance remain to be addressed.
Researchers found that African Americans and Native Americans are more likely to be diagnosed with advanced disease and die of their disease compared to Asian Americans and non-Hispanic whites. The study highlights the importance of considering heterogeneity within broad racial/ethnic categories when evaluating cancer risks.
A new study found that anal cancer precursors are common among HIV-negative, sexually active men who have sex with men, regardless of age. The study also identified risk factors for these precancerous lesions, including HPV infection and having multiple male sex partners.
A phase I study has shown early promise for a cancer-killing virus targeting colorectal cancer. The virus, NV1020, selectively kills cancer cells while sparing normal tissue, leading to improved CEA reductions and median survival times of up to 23 months.
Researchers found that a diet high in vitamin B6 may reduce the risk of colorectal cancer in women, particularly those who consume alcohol. The study suggests that maintaining a normal or high intake of vitamin B6 can help prevent the development of cancerous polyps in the colon.
The UK Appalachia Community Cancer Network will focus on prevention and early detection of specific cancers with high incidence rates in the region. The network builds on the progress made by a previous program and aims to address the high cancer burden in Appalachian communities.
Studies show that smoking, red meat intake, and alcohol use increase the risk of serious gastrointestinal cancers. Patients who used tobacco and/or alcohol were diagnosed three to five years earlier on average than those who never smoked or drank.
A study found that cetuximab, an Erbitux-based treatment, helped shrink tumors and extend survival in patients with metastatic colorectal cancer who had previously failed treatment. The typical patient survived 6.6 months after treatment.
Panitumumab demonstrated a median survival time of 37.6 weeks and tumor response for 29% of patients with mCRC. The study confirmed safety and efficacy findings previously reported, suggesting panitumumab as an additional treatment option for managing the disease.
New fluorescent technology, Onco-LIFE, improves colonoscopy's diagnostic capability by increasing tumor detection and accuracy. The Aer-O-Scope device offers a self-propelling, self-navigating option for colon cancer screening, potentially reducing discomfort and improving success rates.
The American Gastroenterological Association emphasizes the importance of standard colonoscopy as the most cost-effective option for an accurate diagnosis of colon cancer. Meanwhile, researchers have identified factors that increase the rate of missed diagnoses during colonoscopies, including patient age, gender, and location of tumor....
A Mayo Clinic-led study has found a genetic biomarker that can predict which patients are most likely to experience unwanted side effects from oxaliplatin-based chemotherapy regimens. This biomarker could enable early identification and alternative treatments for patients at risk of nerve damage.
A meta-analysis of 35 studies found CT colonography to have a high sensitivity and specificity for detecting polyps and colorectal cancer, making it a promising alternative for screening. The study's findings suggest that CT colonography could increase patient compliance and improve early detection rates.
Researchers from Thomas Jefferson University have successfully created plant factories that produce antibodies against tumor cells, offering a potential alternative to expensive and traditional methods. The plant-made antibodies show similar effectiveness in inhibiting tumor growth as mammalian-made monoclonal antibodies.
A Northwestern Memorial HealthCare study identified a gene variant TGFBR1*6A associated with a high risk of colorectal cancer. The variant was found to be more prevalent among patients without a mutation in other genes, suggesting its potent contribution to familial cases.
Researchers found a modest increase in colorectal cancer incidence in families without MMR deficiency, but no increased risk for other malignancies. These findings allow clinicians to provide more accurate and lower-risk information to affected families.
The revised Bethesda guidelines effectively identify patients at risk for hereditary nonpolyposis colorectal cancer (HNPCC), also known as Lynch syndrome. A study of 1,222 patients found that these guidelines are the most effective way to detect MSH2 or MLH1 gene carriers.